Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Current Leases (2019 - 2021)

Cogent Biosciences has reported Current Leases over the past 3 years, most recently at $2.3 million for Q3 2021.

  • Quarterly results put Current Leases at $2.3 million for Q3 2021, up 13.33% from a year ago — trailing twelve months through Sep 2021 was $2.3 million (up 13.33% YoY), and the annual figure for FY2020 was $2.1 million, up 26.74%.
  • Current Leases for Q3 2021 was $2.3 million at Cogent Biosciences, up from $2.2 million in the prior quarter.
  • Over the last five years, Current Leases for COGT hit a ceiling of $2.3 million in Q3 2021 and a floor of $1.5 million in Q1 2019.
  • Median Current Leases over the past 3 years was $1.7 million (2020), compared with a mean of $1.8 million.
  • Biggest five-year swings in Current Leases: rose 10.02% in 2020 and later grew 28.62% in 2021.
  • Cogent Biosciences' Current Leases stood at $1.6 million in 2019, then grew by 26.74% to $2.1 million in 2020, then increased by 9.8% to $2.3 million in 2021.
  • The last three reported values for Current Leases were $2.3 million (Q3 2021), $2.2 million (Q2 2021), and $2.1 million (Q1 2021) per Business Quant data.